Solaria Bio
2 known investors
Find your way into Solaria Bio
Sign up to see every warm intro you have to Solaria Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Solaria Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solaria develops plant-sourced living synbiotics (probiotic-prebiotic products) marketed as medical foods for inflammatory conditions, starting with Bōndia for bone loss in women with osteopenia and a forthcoming product, Arthrīva, for rheumatoid arthritis. The company builds a library of plant-based microbiome solutions backed by clinical trials and a Harvard Medical School partnership.
Investors · 2
Frequently asked questions
- What does Solaria Bio do?
- Solaria develops plant-sourced living synbiotics (probiotic-prebiotic products) marketed as medical foods for inflammatory conditions, starting with Bōndia for bone loss in women with osteopenia and a forthcoming product, Arthrīva, for rheumatoid arthritis. The company builds a library of plant-based microbiome solutions backed by clinical trials and a Harvard Medical School partnership.
- Who are Solaria Bio's investors?
- Solaria Bio's investors include Bold Capital Partners, Olive Tree Capital.

